RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

Hi Neuro, Sounds like CNS funding has returned in a big way, so that's a major plus. Dr. Lippa's backround includes funding, startups, turnarounds, etc, which should also help. In the presentation he said they were "just about to begin" the two CX-1739 studies, so it sounds like he probably has some funding lined up.

It sure has been a long strange trip with ole Cor, but at least things appear to be rolling again. Any general thoughts on Dr. Lippa's overall track record and ability to deliver? I remember some of the Indiplon saga from Neurocrine, but not much about the Dov Pharma connection. Lippa appears to have considerable backround in the funding area (Aurora, Fusion Assoc), in contrast to previous Cor management.

Thanks for any insights :o)